The “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” is the third member of
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …

ABSTRACT COVID-19, a respiratory infectious disease, occurs due to Severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). Millions of individuals around the world …

Designing and producing an effective vaccine is the best possible way to reduce the burden
and spread of a disease. During the coronavirus disease 2019 (COVID-19) pandemic, many …

Even after over 2 years of the COVID-19 pandemic, research on rapid, inexpensive, and
accurate tests remains essential for controlling and avoiding the global spread of SARS-CoV …

Vaccines remain the best approach for the prevention of infectious diseases. Protein subunit
vaccines are safe compared to live-attenuated whole cell vaccines but often show reduced …

The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …

While the vaccination was introduced as a promising tool to control the Coronavirus disease
2019 (COVID-19) pandemic, concerns about vaccine-related side effects had grown. Due to …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-caused Coronavirus
Disease 2019 (COVID-19) is currently a global pandemic that has wreaked havoc on public …

Background and objectives The coronavirus SARS‐CoV‐2, which is the cause of COVID‐19
disease in infected patients, has led to an ongoing worldwide pandemic. Although SARS …

Vaccine development against SARS-CoV-2 has been highly successful in slowing down the
COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole …